(NYSE: LLY) Eli Lilly & Co's forecast annual revenue growth rate of 18.58% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 9.06%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.42%.
Eli Lilly & Co's revenue in 2026 is $65,179,000,000.On average, 33 Wall Street analysts forecast LLY's revenue for 2026 to be $78,066,599,934,680, with the lowest LLY revenue forecast at $73,511,126,953,500, and the highest LLY revenue forecast at $87,737,900,204,520. On average, 32 Wall Street analysts forecast LLY's revenue for 2027 to be $90,578,349,396,140, with the lowest LLY revenue forecast at $81,773,994,595,280, and the highest LLY revenue forecast at $102,673,134,877,960.
In 2028, LLY is forecast to generate $102,377,864,005,500 in revenue, with the lowest revenue forecast at $89,204,820,992,620 and the highest revenue forecast at $119,499,801,178,500.